AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 82 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $168,000 | -74.6% | 360,000 | 0.0% | 0.00% | – |
| Q1 2021 | $662,000 | +24.2% | 360,000 | 0.0% | 0.00% | – |
| Q4 2020 | $533,000 | +80.7% | 360,000 | 0.0% | 0.00% | – |
| Q3 2020 | $295,000 | +19.0% | 360,000 | 0.0% | 0.00% | – |
| Q2 2020 | $248,000 | +24700.0% | 360,000 | +22414.1% | 0.00% | – |
| Q4 2018 | $1,000 | – | 1,599 | +132.8% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 687 | +22.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 563 | +2581.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 21 | -97.6% | 0.00% | – |
| Q1 2015 | $7,000 | +133.3% | 872 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | -98.2% | 872 | -98.2% | 0.00% | – |
| Q3 2014 | $168,000 | +2000.0% | 47,664 | +4714.5% | 0.00% | – |
| Q2 2014 | $8,000 | – | 990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |